Ignite Creation Date:
2024-05-06 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 12:44 PM
Study NCT ID:
NCT03505554
Status:
RECRUITING
Last Update Posted:
2023-08-07
First Post:
2018-04-06
Brief Title:
A Study of Oral Lorlatinib in Patients With Relapsed ALK Positive Lymphoma
Sponsor:
University of Milano Bicocca
Organization:
University of Milano Bicocca